Correction: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox.

This document is a correction notice for an article titled "Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox" published in BMC Cancer. The authors have identified an error in the original article, specifically in Figure 2a, where two images overlap. The corrected version of Figure 2 is provided in this correction article. The article discusses the effect of deferasirox on the migratory ability of pancreatic cancer cells using various cell lines. The authors measured the percentage of wound closure as an index of cell migration and found significant differences compared to the control group. [Extracted from the article]

Copyright of BMC Cancer is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)